Go to homepage
Go to homepage
Your Cart
US$0.00

Peptide ELISA for Research

Peptide ELISA is an essential tool for measuring antigen-specific immune responses and assessing the efficacy of vaccines and immunotherapies. JPT’s Peptide ELISA technology supports various applications, including cancer research and infectious disease studies. Below, you will find key studies referencing JPT’s Peptide ELISA in research.

References with Peptide ELISA

2023

2023

  • Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
    Hoefges et al., BioRXiv (2023) - PMID: 36896021
  • Characterization of surface-exposed structural loops as insertion sites for foreign antigen delivery in calicivirus-derived VLP platform
    Panasiuk et al., Frontiers in Microbiology (2023) - PMID: 36922971
2021

2021

  • Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
    Loyal et al., Science (2021) - PMID: 34465633
  • R1441G but not G2019S Mutation Enhances LRRK2 Mediated Rab10 Phosphorylation in Human Peripheral Blood Neutrophils
    Fan et al., Acta Pathol. (2021) - PMID: n.a.
  • JNJ-64794964 (AL-034/TQ-A3334), a TLR7 Agonist, Induces Sustained Anti-HBV Activity in AAV/HBV Mice Via Non-Cytolytic Mechanisms
    Herschke et al., Antiviral Research (2021) 
  • Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
    Akache et al., Pharmaceutical Research (2021) - PMID: 33673382
  • COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity
    Jeong et al., Vaccine (2021) - PMID: 34579194
  • A Rapid and Reliable Liquid Chromatography/mass Spectrometry Method for SARS-CoV-2 Analysis from Gargle Solutions and Saliva
    Kipping et al., Analytical and Bioanalytical Chemistry (2021) - PMID: 34427712
  • SARS-CoV-2 Protein Subunit Vaccination of Mice and Rhesus Macaques Elicits Potent and Durable Neutralizing Antibody Responses
    Mandolesi et al., Cell Reports Medicine (2021) - PMID: 33842900
  • Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
    Ong et al., Computational and Structural Biotechnology Journal (2021) - PMID: 33398234
  • Single Prime hAd5 Spike (S) + Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean S- and N- T-Cell Responses Equivalent to T-Cell Responses from Patients Previously Infected with SARS-CoV-2
    Sieling et al., MedRXiv (2021) 
  • A Highly Specific Assay for the Detection of SARS-CoV-2–Reactive CD4+ and CD8+ T Cells in COVID-19 Patients
    Zelba et al., Journal of Immunology (2021) - PMID: 33298615
Archive

Archive

  • Serological Profiling of the EBV Immune Response in Chronic Fatigue Syndrome using a Peptide Microarray
    Loebel et al., PLoS One (2017) - PMID: 28604802
  • Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
    Huber et al., PLoS One (2017) - PMID: 28056100
  • Evaluating the Efficacy of Aluminium Phosphate Formulated L2 Based HPV Vaccine
    Lakshmikanth et al., Asian Journal of Pharmaceutical and Clinical Research (2015) - PMID: n.a
  • Restrictive IgG Antibody Response Against Mutated Citrullinated Vimentin Predicts Response to Rituximab in Patients with Rheumatoid Arthritis
    Lindenberg et al., Arthritis Research & Therapy (2015) - PMID: 26268352
  • 052. Patients with Early Inflammatory Arthritis Who are Anti-CCP Antibody Positive have Antibodies Against Acetylated and Carbamylated Vimentin Peptides
    Juarez et al., Rheumatology (2015) - PMID: n.a.
  • Identification of Novel Antiacetylated Vimentin Antibodies in Patients with Early Inflammatory Arthritis
    Juarez et al., Ann Rheum Dis (2015) - PMID: n.a
Loading...
Peptide ELISA

Check our list of products, click and go.

Get a quote